John P. Butler - 30 Jan 2026 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
CEO and President, Director
Signature
/s/ Carolyn M. Rucci, attorney-in-fact for John P. Butler
Issuer symbol
AKBA
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 16:35:35 UTC
Previous filing
04 Mar 2025
Next filing
04 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Butler John P. CEO and President, Director C/O AKEBIA THERAPEUTICS, INC., 245 FIRST STREET, CAMBRIDGE /s/ Carolyn M. Rucci, attorney-in-fact for John P. Butler 03 Feb 2026 0001591467

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Award $0 +743,000 +27% $0.000000 3,463,849 30 Jan 2026 Direct F1, F2
holding AKBA Common Stock 159,928 30 Jan 2026 Held by Dorothy Butler Revocable Trust November 20, 2007

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKBA Stock Option (Right to buy) Award $0 +1,115,000 $0.000000 1,115,000 30 Jan 2026 Common Stock 1,115,000 $1.41 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
F2 Includes 159,928 shares previously held by John Butler 2019 GRAT, and 1,500 shares of the Issuer's common stock purchased on June 30, 2025 and 1,500 shares of the Issuer's common stock purchased on December 31, 2025, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
F3 The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.